4//SEC Filing
Dolan Matthew Vincent 4
Accession 0001093557-24-000056
CIK 0001093557other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:55 PM ET
Size
9.4 KB
Accession
0001093557-24-000056
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Dolan Matthew Vincent
EVP, Strategy & Corporate Dev
Transactions
- Sale
Common Stock
2024-03-15$129.18/sh−1,886$243,641→ 46,684 total - Sale
Common Stock
2024-03-15$130.77/sh−1,314$171,832→ 45,370 total - Sale
Common Stock
2024-03-15$131.39/sh−1,003$131,785→ 44,367 total
Footnotes (5)
- [F1]On December 15, 2023, Mr. Dolan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $128.78 to $129.645. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Included in this number are 40,075 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 3,852 of which were granted on March 8, 2022 and shall vest through March 8, 2025.
- [F4]This transaction was executed in multiple trades at prices ranging from $130.165 to $130.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $131.20 to $131.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001914994
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:55 PM ET
- Size
- 9.4 KB